A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 13,466 shares of DVAX stock, worth $138,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,466
Previous 10,269 31.13%
Holding current value
$138,430
Previous $131,000 32.82%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 21, 2025

BUY
$12.39 - $14.4 $39,610 - $46,036
3,197 Added 31.13%
13,466 $174,000
Q4 2024

Feb 10, 2025

BUY
$10.28 - $13.66 $105,565 - $140,274
10,269 New
10,269 $131,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.3B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Envestnet Portfolio Solutions, Inc. Portfolio

Follow Envestnet Portfolio Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Portfolio Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Portfolio Solutions, Inc. with notifications on news.